BRAIN BTA Stock Overview
A medical device company, together with its subsidiaries, engages in the development, marketing, and sale of medical cooling systems for the healthcare sector in Sweden.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
BrainCool AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 2.41 |
| 52 Week High | SEK 2.57 |
| 52 Week Low | SEK 1.55 |
| Beta | 1.62 |
| 11 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 46.95% |
Recent News & Updates
Recent updates
Shareholder Returns
| BRAIN BTA | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | 2.6% | -0.9% | -1.6% |
| 1Y | n/a | 1.2% | 12.3% |
Return vs Industry: Insufficient data to determine how BRAIN BTA performed against the Swedish Medical Equipment industry.
Return vs Market: Insufficient data to determine how BRAIN BTA performed against the Swedish Market.
Price Volatility
| BRAIN BTA volatility | |
|---|---|
| BRAIN BTA Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.3% |
| Market Average Movement | 5.8% |
| 10% most volatile stocks in SE Market | 12.1% |
| 10% least volatile stocks in SE Market | 3.4% |
Stable Share Price: BRAIN BTA's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine BRAIN BTA's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 22 | Jon Berg | braincoolinc.com |
BrainCool AB (publ), a medical device company, together with its subsidiaries, engages in the development, marketing, and sale of medical cooling systems for the healthcare sector in Sweden. The company offers products for medical cooling treatments for a range of diseases, including stroke, sudden cardiac arrest, oral mucositis, and migraine. It provides BrainCool and RhinoChill systems that facilitates rapid medical cooling treatment in an emergency setting and ensures the continuum of care; Cooral system provides medical professionals an easy way to reduce the risk of oral mucositis; and IQool system offers an easy-to-use intuitive interface, informative graphics, and an automatic feedback loop allowing clinicians to manage their patient rather than a device.
BrainCool AB (publ) Fundamentals Summary
| BRAIN BTA fundamental statistics | |
|---|---|
| Market cap | SEK 605.49m |
| Earnings (TTM) | -SEK 57.05m |
| Revenue (TTM) | SEK 33.18m |
18.2x
P/S Ratio-10.6x
P/E RatioIs BRAIN BTA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BRAIN BTA income statement (TTM) | |
|---|---|
| Revenue | SEK 33.18m |
| Cost of Revenue | SEK 19.15m |
| Gross Profit | SEK 14.03m |
| Other Expenses | SEK 71.09m |
| Earnings | -SEK 57.05m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 15, 2024
| Earnings per share (EPS) | -0.23 |
| Gross Margin | 42.29% |
| Net Profit Margin | -171.95% |
| Debt/Equity Ratio | 0% |
How did BRAIN BTA perform over the long term?
See historical performance and comparison